Global Leukocyte Surface Antigen CD47 Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Leukocyte Surface Antigen CD47 Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Leukocyte Surface Antigen CD47 report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Leukocyte Surface Antigen CD47 market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Lymphoma and Ovarian Cancer are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Leukocyte Surface Antigen CD47 industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Leukocyte Surface Antigen CD47 key manufacturers include Aurigene Discovery Technologies Ltd, Celgene Corp, Forty Seven Inc, Surface Oncology Inc and Trillium Therapeutics Inc, etc. Aurigene Discovery Technologies Ltd, Celgene Corp, Forty Seven Inc are top 3 players and held % sales share in total in 2022.
Leukocyte Surface Antigen CD47 can be divided into B-6H12, ALX-148, CC-90002 and PSTx-23, etc. B-6H12 is the mainstream product in the market, accounting for % sales share globally in 2022.
Leukocyte Surface Antigen CD47 is widely used in various fields, such as Lymphoma, Ovarian Cancer, Ischemia Reperfusion Injury and Kindney Transplant Rejection, etc. Lymphoma provides greatest supports to the Leukocyte Surface Antigen CD47 industry development. In 2022, global % sales of Leukocyte Surface Antigen CD47 went into Lymphoma filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Leukocyte Surface Antigen CD47 market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Aurigene Discovery Technologies Ltd
Celgene Corp
Forty Seven Inc
Surface Oncology Inc
Trillium Therapeutics Inc
Segment by Type
B-6H12
ALX-148
CC-90002
PSTx-23
Others
Lymphoma
Ovarian Cancer
Ischemia Reperfusion Injury
Kindney Transplant Rejection
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Leukocyte Surface Antigen CD47 market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Leukocyte Surface Antigen CD47, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Leukocyte Surface Antigen CD47 industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Leukocyte Surface Antigen CD47 in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Leukocyte Surface Antigen CD47 introduction, etc. Leukocyte Surface Antigen CD47 Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Leukocyte Surface Antigen CD47 market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
North America, Europe and Asia Pacific are the key regions for Leukocyte Surface Antigen CD47 industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Leukocyte Surface Antigen CD47 key manufacturers include Aurigene Discovery Technologies Ltd, Celgene Corp, Forty Seven Inc, Surface Oncology Inc and Trillium Therapeutics Inc, etc. Aurigene Discovery Technologies Ltd, Celgene Corp, Forty Seven Inc are top 3 players and held % sales share in total in 2022.
Leukocyte Surface Antigen CD47 can be divided into B-6H12, ALX-148, CC-90002 and PSTx-23, etc. B-6H12 is the mainstream product in the market, accounting for % sales share globally in 2022.
Leukocyte Surface Antigen CD47 is widely used in various fields, such as Lymphoma, Ovarian Cancer, Ischemia Reperfusion Injury and Kindney Transplant Rejection, etc. Lymphoma provides greatest supports to the Leukocyte Surface Antigen CD47 industry development. In 2022, global % sales of Leukocyte Surface Antigen CD47 went into Lymphoma filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Leukocyte Surface Antigen CD47 market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Aurigene Discovery Technologies Ltd
Celgene Corp
Forty Seven Inc
Surface Oncology Inc
Trillium Therapeutics Inc
Segment by Type
B-6H12
ALX-148
CC-90002
PSTx-23
Others
Segment by Application
Lymphoma
Ovarian Cancer
Ischemia Reperfusion Injury
Kindney Transplant Rejection
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Leukocyte Surface Antigen CD47 market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Leukocyte Surface Antigen CD47, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Leukocyte Surface Antigen CD47 industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Leukocyte Surface Antigen CD47 in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Leukocyte Surface Antigen CD47 introduction, etc. Leukocyte Surface Antigen CD47 Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Leukocyte Surface Antigen CD47 market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices